SCHEMBL16925442

SCHEMBL16925442

CC(=O)OC[C@@H]1C[C@H]1C#CC#Cc1ccc(C(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 5/20 0.37
▸ RARG P13631 5/20 0.37
▸ ACACB O00763 1/20 0.36
▸ CYP3A4 P08684 4/20 0.35
▸ CYP2C9 P11712 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ RARA P10276 2/20 0.34
▸ CYP26A1 O43174 1/20 0.34
▸ CRABP2 P29373 1/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ PTPN11 Q06124 1/20 0.33
▸ HSD17B10 Q99714 2/20 0.32
▸ POLB P06746 1/20 0.32
▸ APEX1 P27695 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13832184 1.00 RARB (0.37) RARBRARGACACBCYP3A4CYP2C9
SCHEMBL13740539 0.88 PTPN11 (0.39) CYP3A4CYP2C9MAPTCYP2D6ALDH1A1
SCHEMBL13738565 0.88 PTPN11 (0.39) CYP3A4CYP2C9MAPTCYP2D6ALDH1A1
SCHEMBL16921533 0.83 RARB (0.41) RARBRARGACACBCYP3A4ALDH1A1
SCHEMBL13737615 0.82 RARB (0.39) RARBRARGACACBCYP3A4ALDH1A1
SCHEMBL31303687 0.82 RARB (0.39) RARBRARGACACBCYP3A4ALDH1A1
SCHEMBL31303689 0.82 RARB (0.39) RARBRARGACACBCYP3A4ALDH1A1
SCHEMBL13738717 0.82 RARB (0.39) RARBRARGACACBCYP3A4ALDH1A1
SCHEMBL13831258 0.82 RARB (0.39) RARBRARGACACBCYP3A4ALDH1A1
SCHEMBL17451854 0.82 RARB (0.39) RARBRARGACACBCYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150203444-A1 POLYMORPHS OF N-((S)-3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-(((1R,2R)-2-(HYDROXYMETHYL)CYCLOPROPYL)BUTA-1,3-DIYNYL)BENZAMIDE ACHAOGEN, INC. (US) 2015-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203444-A1 POLYMORPHS OF N-((S)-3-AMINO-1-(HYDROXYAMINO)-3-METHYL-1-OXOBUTAN-2-YL)-4-(((1R,2R)-2-(HYDROXYMETHYL)CYCLOPROPYL)BUTA-1,3-DIYNYL)BENZAMIDE BBC3, HBG1, CYP1B1 RARB 1381/4885RARG 2142/4885ACACB 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback